Last updated: July 13, 2026

Application No. 18/838,512

Untitled Application

Unknown

Filed

1600

Priority

Feb 14, 2022 — provisional 63/309,932 +2 more

Examiner

SZNAIDMAN, MARCOS L

Art Unit

1629

Tech Center

Novartis AG

Assignee

Novartis AG

OA Round

1 (Non-Final)

This examiner grants 37% of cases after interview

— +15.8% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1264 resolved cases, 2023–2026

Examiner Intelligence

SZNAIDMAN, MARCOS L View full profile →

Grants only 37% of cases

Career Allowance Rate

468 granted / 1264 resolved

-23.0% vs TC avg

Strong +16% interview lift

Without

With

+15.8%

Interview Lift

resolved cases with interview

Typical timeline

3y 6m

Avg Prosecution

48 currently pending

Career history

1320

Total Applications

across all art units

Statute-Specific Performance

§101

0.6%

-39.4% vs TC avg

§103

48.0%

+8.0% vs TC avg

§102

12.1%

-27.9% vs TC avg

§112

16.4%

-23.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1264 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/327,929

Patent 12667556

EXTENDED RELEASE INJECTABLE FORMULATIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF

5y 1m to grant Granted Jun 30, 2026

17/799,637

Patent 12667559

DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

3y 10m to grant Granted Jun 30, 2026

16/970,654

Patent 12661328

METHODS OF TREATING ANTI-NMDAR-ASSOCIATED NEUROPSYCHIATRIC DISORDERS

5y 10m to grant Granted Jun 23, 2026

17/309,847

Patent 12661356

L718 AND/OR L792 MUTANT TREATMENT-RESISTANT EGFR INHIBITOR

5y 0m to grant Granted Jun 23, 2026

16/885,815

Patent 12653891

Stable Glucocorticoid Formulation

6y 0m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

37%

Grant Probability

53%

With Interview (+15.8%)

3y 6m

Median Time to Grant

Low

PTA Risk

Based on 1264 resolved cases by this examiner. Grant probability derived from career allowance rate.